Arysta LifeScience Europe recently announced a new organizational structure to leverage its scale and accelerate the company's growth in this key market. The new European management structure, which is effective immediately, is designed to further strengthen the company’s current performance while capitalizing on long-term growth opportunities.
“We are eager to capitalize on the unique growth opportunities that will emerge from having Arysta LifeScience, Chemtura AgroSolutions and Agriphar under one umbrella,” said José Nobre, Arysta LifeScience’s new Business Unit President, Europe. “Our newly-created company, Arysta LifeScience, possesses a strong bias toward high-growth areas; and with an industry-leading portfolio of active ingredients and registrations, we believe we are ideally
positioned to continue developing solutions that will address the evolving demands of farmers around Europe.”
The company says it now can offer all its customers a more complete portfolio of traditional crop protection products, seed treatments, biological products, biostimulants, innovative nutrition and adjuvants.
The new leadership team that will manage the Europe Business Unit includes: Paul Thomson as Head of Research & Development, Jozef Michrina as Head of Marketing, Guy de Froberville as Head of Commercial Distribution countries and third-party relations, Hildo Brilleman as Head of Central & Eastern Europe, Gilles Cerutti as Head of Operations & Supply Chain, Wim van de Wiele as Chief Financial Officer, Guilhem de Gaillard as Legal Counsel Ag Division and Michel Bihry as Head of Human Resources.
The new Arysta LifeScience integration team is working to develop one face to the customer before the end of this year, in time for the 2016 marketing and sales season.
“Our global footprint and strong presence in Europe, with over $450m of sales, 14 subsidiaries and two world-class formulation and packaging sites, will give us the flexibility to meet local needs and provide our customers and business partners growth opportunities that benefit all,” Nobre added.